Computational analysis of drug resistance of taxanes bound to human β-tubulin mutant (D26E)
- 15 May 2023
- journal article
- research article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 123, 108503
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (PSCA170090P)
- National Science Foundation (XSEDE MCB 170088)
- National Science Foundation (ACI-1429467/RUI-1904797)
- New Jersey Health Foundation (PC 76-21)
This publication has 35 references indexed in Scilit:
- Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospectsJournal of Pharmacology and Pharmacotherapeutics, 2013
- Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant TumorsClinical Cancer Research, 2013
- The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, Function, and Bioinformatics, 2011
- UniProt Knowledgebase: a hub of integrated protein dataDatabase: The Journal of Biological Databases and Curation, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Differences in Paclitaxel and Docetaxel Interactions with Tubulin Detected by Mutagenesis of Yeast TubulinChemMedChem, 2008
- Gaussian split Ewald: A fast Ewald mesh method for molecular simulationThe Journal of Chemical Physics, 2005
- Partial rigid‐body dynamics in NPT, NPAT and NPγT ensembles for proteins and membranesJournal of Computational Chemistry, 2004
- Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validationJournal of Computational Chemistry, 2002
- Docking ligands onto binding site representations derived from proteins built by homology modellingJournal of Molecular Biology, 2001